Hot Pursuit     25-May-24
Auro Pharma's Telangana facility gets ‘OAI’ classification
The US drug regulator conducted its inspection from 22 January 2024 to 2 February 2024.
The United States Food and Drug Administration (USFDA) conducted an inspection the Unit-III, a formulation manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of Auro Pharma, situated at Pashamylaram, Telangana.

Subsequently, the US FDA has determined the inspection classification status of this facility as ‘official action indicated (OAI)’.

The company stated that it remains committed to work closely with the US FDA and continues to enhance its compliance on an ongoing basis.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.51% to end at Rs 1,235.05 on Friday, 24 May 2024.

Previous News
  Nifty hovers above 23,050; PSU banks in demand
 ( Market Commentary - Mid-Session 27-May-24   14:30 )
  Auro Pharma Q4 PAT jumps 80% YoY to Rs 909 crore
 ( Hot Pursuit - 27-May-24   12:34 )
  Aurobindo Pharma consolidated net profit rises 79.50% in the March 2024 quarter
 ( Results - Announcements 27-May-24   08:39 )
  Auro Pharma's Telangana facility gets ‘OAI’ classification
 ( Hot Pursuit - 25-May-24   17:08 )
  Eugia Pharma Specialities' Unit III completes USFDA inspection
 ( Corporate News - 25-May-24   12:11 )
  Aurobindo Pharma Ltd spurts 0.15%, gains for five straight sessions
 ( Hot Pursuit - 22-May-24   13:00 )
  Aurobindo Pharma Ltd spurts 3.21%
 ( Hot Pursuit - 18-May-24   13:05 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-May-24   12:42 )
  Apitoria Pharma's Unit VII completes USFDA inspection
 ( Corporate News - 10-May-24   15:03 )
  Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 7 observations
 ( Hot Pursuit - 04-May-24   14:38 )
  USFDA completes inspection of Eugia Pharma Specialities' Unit II
 ( Corporate News - 03-May-24   19:20 )
Other Stories
  Inox Green Energy board OKs fund raising proposal
  22-Jun-24   17:00
  Cipla Goa facility gets 6 USFDA observations
  22-Jun-24   16:22
  EIH CFO Kallol Kundu resigns
  22-Jun-24   14:20
  Sky Gold acquires entire stake in Starmangalsutra & Sparkling Chains
  22-Jun-24   13:31
  TVS Motor inks pact with CSC Grameen eStores for its CV range
  22-Jun-24   12:27
  Prestige Estates to raise Rs 5000 crore via QIP
  22-Jun-24   11:59
  JSW Energy arm bags LoA from SECI
  22-Jun-24   10:56
  RVNL emerges as L-1 bidder for Rs 191-cr railway project
  22-Jun-24   09:54
  Bajaj Consumer hits 52-week high as board OKs Rs 166-cr share buyback
  21-Jun-24   15:28
  GRM Overseas rallies as board OKs Rs 136-cr preferential issue
  21-Jun-24   15:19
Back Top